Sarissa Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-90,000
Closed -$14.6M 17
2015
Q4
$14.6M Hold
90,000
2.84% 9
2015
Q3
$12.4M Sell
90,000
-110,000
-55% -$17.3M 3.07% 9
2015
Q2
$30.7M Sell
200,000
-118,000
-37% -$18.9M 7.07% 6
2015
Q1
$50.8M Hold
318,000
10.72% 4
2014
Q4
$50.7M Buy
318,000
+198,000
+165% +$30.9M 17.93% 3
2014
Q3
$16.9M Buy
120,000
+75,000
+167% +$9.79M 6.51% 6
2014
Q2
$5.33M Buy
+45,000
New +$5.21M 1.81% 8

Other funds holding AMGN

Sarissa Capital Management's AMGN Position: Q1 2016 in Review

Sarissa Capital Management sold out of Amgen (AMGN) in Q1 2016, closing a stake of 90,000 shares — an estimated $14.6M sold.

Sarissa Capital Management first reported a position in AMGN in Q2 2014 and held it in 7 quarters. The position peaked at $50.8M in Q1 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Sarissa Capital Management reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
  • Sarissa Capital Management sold 90,000 Amgen shares in Q1 2016, an estimated $14.6M.
  • Sarissa Capital Management first reported a position in Amgen in Q2 2014 and held it in 7 quarters.
  • Sarissa Capital Management's Amgen position peaked at $50.8M in Q1 2015.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Sarissa Capital Management's 13F filing for Q1 2016, filed 16 May 2016.